Repeated intrathecal administration of ropivacaine causes neurotoxicity in rats

Anaesthesia and Intensive Care

Volumn 40, Issue 5, 2012, Pages 825-831

  Sun, Z H ^a   Xu, X P ^a   Song, Z B ^a   Zhang, Z ^a   Wang, N ^a   Guo, Q L ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Akt; Intrathecal; Neurotoxicity; Ropivacaine; Subarachnoid

Indexed keywords

PROTEIN KINASE B; ROPIVACAINE; SODIUM CHLORIDE;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CELL PROLIFERATION; CELL STRUCTURE; EDEMA; ELECTRON MICROSCOPY; GLIA CELL; HYPERALGESIA; IMMUNOREACTIVITY; MALE; MECHANICAL ALLODYNIA; MICROSCOPY; NERVE CELL LESION; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD; THERMAL HYPERALGESIA;

EID: 84866538079     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000427     Document Type: Article

References (28)

1. Denny NM, Selander DE. Continuous spinal anaesthesia. Br J Anaesth 1998; 81:590-597.
2. Michalek-Sauberer A, Kozek-Langenecker SA, Heinzl H, Deusch E, Chiari A. Median effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia administered via a spinal catheter for brachytherapy of the lower abdomen. Reg Anesth Pain Med 2008; 33:4-9.
3. Luck JF, Fettes PDW, Wildsmith JAW. Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine. Br J Anaesth 2008; 101:705-710.
4. Qian XW, Chen XZ, Li DB. Low-dose ropivacaine-sufentanil spinal anaesthesia for caesarean delivery: a randomised trial. Int J Obstet Anesth 2008; 17:309-314.
5. Abrão J, Bianco Mde P, Roma W, Krippa JE, Hallak JE. Spinal myoclonus after subarachnoid anesthesia with bupivacaine. Rev Bras Anestesiol 2011; 61:619-623, 339-340.
6. Edomwonyi NP, Isesele TO. Transient neurological symptoms following spinal anesthesia for cesarean section. Middle East J Anesthesiol 2010; 20:809-813.
7. Zink W, Graf Bernhard M. The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine. Curr Opin Anaesthesiol 2008; 21:645-650.
8. De Kock M, Gautier P, Fanard L, Hody JL, Lavand'homme P. Intrathecal ropivacaine and clonidine for ambulatory knee arthroscopy: a dose-response study. Anesthesiology 2001; 94:574-578.
9. McDonald SB, Liu SS, Kopacz DJ, Stephenson CA. Hyperbaric spinal ropivacaine: a comparison to bupivacaine in volunteers. Anesthesiology 1999; 90:971-977.
10. Kingon A, Sambrook P, Goss A. Higher concentration local anaesthetics causing prolonged anaesthesia. Do they? A literature review and case reports. Aust Dent J 2011; 56:348-351.
11. Gosch UW, Hueppe M, Hallschmid M, Born J, Schmucker P, Meier T. Post-dural puncture headache in young adults: comparison of two small-gauge spinal catheters with different needle design. Br J Anaesth 2005; 94:657-661.
12. Zhong Z, Qulian G, Yuan Z, Wangyuan Z, Zhihua S. Repeated intrathecal administration of ropivacaine causes neurotoxicity in rats. Anaesth Intensive Care 2009; 37:929-936.
13. Choi JS, Park HJ, Kim HY, Kim SY, Lee JE, Choi YS et al. Phosphorylation of PTEN and Akt in astrocytes of the rat hippocampus following transient forebrain ischemia. Cell Tissue Res 2005; 319:359-366.
14. Nakajima T, Iwabuchi S, Miyazaki H, Okuma Y, Kuwabara M, Nomura Y et al. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain. J Vet Med Sci 2004; 66:521-527.
15. Xu F, Li T, Zhang B. An improved method for protecting and fixing the lumbar catheters placed in the spinal subarachnoid space of rats. J Neurosci Methods 2009; 183:114-118.
16. Malinovsky JM, Charles F, Baudrimont M, Pereon Y, Le Corre P, Pinaud M et al. Intrathecal ropivacaine in rabbits: pharmacodynamic and neurotoxicologic study. Anesthesiology 2002; 97:429-435.
17. Rose FX, Estebe JP, Ratajczak M, Wodey E, Chevanne F, Dollo G et al. Epidural, intrathecal pharmacokinetics, and intrathecal bioavailability of ropivacaine. Anesth Analg 2007; 105:859-867.
18. Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, Marchand F et al. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 2007; 104:10655-10660.
19. Takenami T, Yagishita S, Murase S, Hiruma H, Kawakami T, Hoka S. Neurotoxicity of intrathecally administered bupivacaine involves the posterior roots/posterior white matter and is milder than lidocaine in rats. Reg Anesth Pain Med 2005; 30:464-472.
20. Yuan Y, Guo Q, Ye Z, Pingping X, Wang N, Song Z. Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stressinduced apoptosis through PI3K-Akt pathway. Brain Res 2011; 1367:85-93.
21. Kim YH, Kim YS, Park CH, Chung IY, Yoo JM, Kim JG et al. Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway. Diabetes 2008; 57:2181-2190.
22. Lirk P, Haller I, Colvin HP, Lang L, Tomaselli B, Klimaschewski L et al. In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Anesth Analg 2008; 106:1456-1464, table of contents.
23. Yamashita A, Matsumoto M, Matsumoto S, Itoh M, Kawai K, Sakabe T. A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg 2003; 97:512-519, table of contents.
24. Dong YJ, Li X. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus injection. Contemp Clin Trials 2012; 33:482-485.
25. Ikeya K. Neurological deficit following lumbar epidural anesthesia with ropivacaine. Masui 2007; 56:945-948.
26. Maurice JM, Gan Y, Ma FX, Chang YC, Hibner M, Huang Y. Bupivacaine causes cytotoxicity in mouse C2C12 myoblast cells: involvement of ERK and Akt signaling pathways. Acta Pharmacol Sin 2010; 31:493-500.
27. Lee ST, Chu K, Park JE, Hong NH, Im WS, Kang L et al. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways. J Neurochem 2008; 104:1190-2000.
28. Sato C, Okabe T, Nakanishi K, Sakamoto A. A case of cancer pain management by long-term intrathecal PCA. J Nihon Med Sch 2010; 77:333-337.